Back to results
US 9,266,952 B2Granted
Antibodies against ROR1 and uses thereof
AssigneeKancera AB
InventorIngrid Teige
Life of this patent
Estimating the term…
Abstract
The invention relates to antibodies for inducing cell death by the specific binding of (ROR1), domains thereof or nucleotide molecules encoding (ROR1). There are also provided methods involving and uses of the antibodies of the invention.
Claims6
An anti-ROR1 antibody comprising a combination of all six CDR regions having the following amino acid sequences:
- (a) CDRH1, SEQ ID NO:
- 57;
- CDRH2, SEQ ID NO:
- 58;
- CDRH3, SEQ ID NO:
- 59, CDRL1, SEQ ID NO:
- 60;
- CDRL2, SEQ ID NO:
- 61;
- and CDRL3, SEQ ID NO:
- 62;
- (b) CDRH1, SEQ ID NO:
- 63;
- CDRH2, SEQ ID NO:
- 64;
- CDRH3, SEQ ID NO:
- 65, CDRL1, SEQ ID NO:
- 66;
- CDRL2, SEQ ID NO:
- 67;
- and CDRL3, SEQ ID NO:
- 68;
- (c) CDRH1, SEQ ID NO:
- 69;
- CDRH2, SEQ ID NO:
- 70;
- CDRH3, SEQ ID NO:
- 71, CDRL1, SEQ ID NO:
- 72;
- CDRL2, SEQ ID NO:
- 73;
- and CDRL3, SEQ ID NO:
- 74;
- (d) CDRH1, SEQ ID NO:
- 75;
- CDRH2, SEQ ID NO:
- 76;
- CDRH3, SEQ ID NO:
- 77, CDRL1, SEQ ID NO:
- 78;
- CDRL2, SEQ ID NO:
- 79;
- and CDRL3, SEQ ID NO:
- 80;
- (e) CDRH1, SEQ ID NO:
- 81;
- CDRH2, SEQ ID NO:
- 82;
- CDRH3, SEQ ID NO:
- 83, CDRL1, SEQ ID NO:
- 84;
- CDRL2, SEQ ID NO:
- 85;
- and CDRL3, SEQ ID NO:
- 86;
- (f) CDRH1, SEQ ID NO:
- 87;
- CDRH2, SEQ ID NO:
- 88;
- CDRH3, SEQ ID NO:
- 89, CDRL1, SEQ ID NO:
- 90;
- CDRL2, SEQ ID NO:
- 91;
- and CDRL3, SEQ ID NO:
- 92;
- (g) CDRH1, SEQ ID NO:
- 93;
- CDRH2, SEQ ID NO:
- 94;
- CDRH3, SEQ ID NO:
- 95, CDRL1, SEQ ID NO:
- 96;
- CDRL2, SEQ ID NO:
- 97;
- and CDRL3, SEQ ID NO:
- 98;
- (h) CDRH1, SEQ ID NO:
- 99;
- CDRH2, SEQ ID NO:
- 100;
- CDRH3, SEQ ID NO:
- 101, CDRL1, SEQ ID NO:
- 102;
- CDRL2, SEQ ID NO:
- 103;
- and CDRL3, SEQ ID NO:
- 104;
- (i) CDRH1, SEQ ID NO:
- 105;
- CDRH2, SEQ ID NO:
- 106;
- CDRH3, SEQ ID NO:
- 107, CDRL1, SEQ ID NO:
- 108;
- CDRL2, SEQ ID NO:
- 109;
- and CDRL3, SEQ ID NO:
- 110;
- (j) CDRH1, SEQ ID NO:
- 111;
- CDRH2, SEQ ID NO:
- 112;
- CDRH3, SEQ ID NO:
- 113, CDRL1, SEQ ID NO:
- 114;
- CDRL2, SEQ ID NO:
- 115;
- and CDRL3, SEQ ID NO:
- 116;
- (k) CDRH1, SEQ ID NO:
- 117;
- CDRH2, SEQ ID NO:
- 118;
- CDRH3, SEQ ID NO:
- 119, CDRL1, SEQ ID NO:
- 120;
- CDRL2, SEQ ID NO:
- 121;
- and CDRL3, SEQ ID NO:
- 122;
- (l) CDRH1, SEQ ID NO:
- 123;
- CDRH2, SEQ ID NO:
- 124;
- CDRH3, SEQ ID NO:
- 125, CDRL1, SEQ ID NO:
- 126;
- CDRL2, SEQ ID NO:
- 127;
- and CDRL3, SEQ ID NO:
- 128;
- or
- (m) CDRH1, SEQ ID NO:
- 129;
- CDRH2, SEQ ID NO:
- 130;
- CDRH3, SEQ ID NO:
- 131, CDRL1, SEQ ID NO:
- 132;
- CDRL2, SEQ ID NO:
- 133;
- and CDRL3, SEQ ID NO:
- 134.
141 more elements
Dependencies are inferred from the claim text.